187 related articles for article (PubMed ID: 16908135)
1. Antitumour properties of fluorinated benzothiazole-substituted hydroxycyclohexa-2,5-dienones ('quinols').
Lion CJ; Matthews CS; Wells G; Bradshaw TD; Stevens MF; Westwell AD
Bioorg Med Chem Lett; 2006 Oct; 16(19):5005-8. PubMed ID: 16908135
[TBL] [Abstract][Full Text] [Related]
2. Quinols as novel therapeutic agents. 2.(1) 4-(1-Arylsulfonylindol-2-yl)-4-hydroxycyclohexa-2,5-dien-1-ones and related agents as potent and selective antitumor agents.
Berry JM; Bradshaw TD; Fichtner I; Ren R; Schwalbe CH; Wells G; Chew EH; Stevens MF; Westwell AD
J Med Chem; 2005 Jan; 48(2):639-44. PubMed ID: 15658878
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of antitumour (1H-1,2,3-triazol-4-yl)-4-hydroxycyclohexa-2,5-dien-1-ones by copper-catalysed Huisgen cycloadditions.
McCarroll AJ; Matthews CS; Wells G; Bradshaw TD; Stevens MF
Org Biomol Chem; 2010 May; 8(9):2078-84. PubMed ID: 20401384
[TBL] [Abstract][Full Text] [Related]
4. Studies on quinones. Part 42: Synthesis of furylquinone and hydroquinones with antiproliferative activity against human tumor cell lines.
Benites J; Valderrama JA; Rivera F; Rojo L; Campos N; Pedro M; José Nascimento MS
Bioorg Med Chem; 2008 Jan; 16(2):862-8. PubMed ID: 17964791
[TBL] [Abstract][Full Text] [Related]
5. Antitumor benzothiazoles. 26.(1) 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (GW 610, NSC 721648), a simple fluorinated 2-arylbenzothiazole, shows potent and selective inhibitory activity against lung, colon, and breast cancer cell lines.
Mortimer CG; Wells G; Crochard JP; Stone EL; Bradshaw TD; Stevens MF; Westwell AD
J Med Chem; 2006 Jan; 49(1):179-85. PubMed ID: 16392802
[TBL] [Abstract][Full Text] [Related]
6. Thioredoxin reductase inhibition by antitumor quinols: a quinol pharmacophore effect correlating to antiproliferative activity.
Chew EH; Lu J; Bradshaw TD; Holmgren A
FASEB J; 2008 Jun; 22(6):2072-83. PubMed ID: 18180330
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of novel 7-azaindazolyl-indolyl-maleimide derivatives as antitumor agents and protein kinase C inhibitors.
Ye Q; Cao J; Zhou X; Lv D; He Q; Yang B; Hu Y
Bioorg Med Chem; 2009 Jul; 17(13):4763-72. PubMed ID: 19447039
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and cytotoxic evaluation of 6-(3-pyrazolylpropyl) derivatives of 1,4-naphthohydroquinone-1,4-diacetate.
Molinari A; Oliva A; Ojeda C; del Corral JM; Castro MA; Cuevas C; San Feliciano A
Arch Pharm (Weinheim); 2009 Oct; 342(10):591-9. PubMed ID: 19753562
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological activity of prodrug inhibitors of the thioredoxin-thioredoxin reductase system.
Wipf P; Lynch SM; Powis G; Birmingham A; Englund EE
Org Biomol Chem; 2005 Nov; 3(21):3880-2. PubMed ID: 16240002
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of 11-substituted 6-aminobenzo[c]phenanthridine derivatives, a new class of antitumor agents.
Kock I; Heber D; Weide M; Wolschendorf U; Clement B
J Med Chem; 2005 Apr; 48(8):2772-7. PubMed ID: 15828815
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological properties of benzothiazole, benzoxazole, and chromen-4-one analogues of the potent antitumor agent 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (PMX 610, NSC 721648).
Aiello S; Wells G; Stone EL; Kadri H; Bazzi R; Bell DR; Stevens MF; Matthews CS; Bradshaw TD; Westwell AD
J Med Chem; 2008 Aug; 51(16):5135-9. PubMed ID: 18666770
[TBL] [Abstract][Full Text] [Related]
12. Antitumour benzothiazoles. Part 10: the synthesis and antitumour activity of benzothiazole substituted quinol derivatives.
Wells G; Bradshaw TD; Diana P; Seaton A; Shi DF; Westwell AD; Stevens MF
Bioorg Med Chem Lett; 2000 Mar; 10(5):513-5. PubMed ID: 10743960
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of C4-fluorinated solamins and their growth inhibitory activity against human cancer cell lines.
Kojima N; Hayashi H; Suzuki S; Tominaga H; Maezaki N; Tanaka T; Yamori T
Bioorg Med Chem Lett; 2008 Dec; 18(24):6451-3. PubMed ID: 18993063
[TBL] [Abstract][Full Text] [Related]
14. 5-Substituted [1]pyrindine derivatives with antiproliferative activity.
Kolb S; Goddard ML; Loukaci A; Mondésert O; Ducommun B; Braud E; Garbay C
Eur J Med Chem; 2010 Mar; 45(3):896-901. PubMed ID: 19969400
[TBL] [Abstract][Full Text] [Related]
15. 3-methyl-2-(4-substituted phenyl)-4,5-dihydronaphtho[1,2-c]-pyrazoles: synthesis and in-vitro biological evaluation as antitumour agents.
Al-Saadi MS; Rostom SA; Faidallah HM
Arch Pharm (Weinheim); 2008 Mar; 341(3):181-90. PubMed ID: 18214843
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antiproliferative activity in vitro of novel (2-butynyl)thioquinolines.
Mól W; Matyja M; Filip B; Wietrzyk J; Boryczka S
Bioorg Med Chem; 2008 Sep; 16(17):8136-41. PubMed ID: 18682326
[TBL] [Abstract][Full Text] [Related]
17. 2,3-Disubstituted-1,4-naphthoquinones, 12H-benzo[b]phenothiazine-6,11-diones and related compounds: synthesis and biological evaluation as potential antiproliferative and antifungal agents.
Tandon VK; Maurya HK; Tripathi A; ShivaKeshava GB; Shukla PK; Srivastava P; Panda D
Eur J Med Chem; 2009 Mar; 44(3):1086-92. PubMed ID: 18708272
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antitumour activity of new muricatacin and goniofufurone analogues.
Popsavin V; Srećo B; Krstić I; Popsavin M; Kojić V; Bogdanović G
Eur J Med Chem; 2006 Oct; 41(10):1217-22. PubMed ID: 16891043
[TBL] [Abstract][Full Text] [Related]
19. Elucidation of thioredoxin as a molecular target for antitumor quinols.
Bradshaw TD; Matthews CS; Cookson J; Chew EH; Shah M; Bailey K; Monks A; Harris E; Westwell AD; Wells G; Laughton CA; Stevens MF
Cancer Res; 2005 May; 65(9):3911-9. PubMed ID: 15867391
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and in vitro evaluation of the anticancer activity of novel fluorinated thiazolo[4, 5-d]pyrimidines.
Fahmy HT; Rostom SA; Saudi MN; Zjawiony JK; Robins DJ
Arch Pharm (Weinheim); 2003 Jul; 336(4-5):216-25. PubMed ID: 12916055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
